Ameriprise
EXAS

Ameriprise’s Exact Sciences EXAS Stock Holding History

Ameriprise’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,717,958
Closed -$174M – 4117
2025
Q4 		$174M Sell
1,717,958
-2,775,127
-62% -$223M 0.04% 409
2025
Q3 		$246M Buy
4,493,085
+2,270,039
+102% +$113M 0.06% 318
2025
Q2 		$118M Sell
2,223,046
-1,140,737
-34% -$58M 0.03% 496
2025
Q1 		$146M Sell
3,363,783
-844,256
-20% -$42.8M 0.04% 403
2024
Q4 		$236M Sell
4,208,039
-317,395
-7% -$19.8M 0.06% 298
2024
Q3 		$308M Buy
4,525,434
+2,310,704
+104% +$130M 0.08% 263
2024
Q2 		$93.6M Sell
2,214,730
-45,252
-2% -$2.49M 0.03% 549
2024
Q1 		$156M Sell
2,259,982
-221,922
-9% -$14M 0.04% 395
2023
Q4 		$184M Sell
2,481,904
-757,744
-23% -$49.7M 0.06% 339
2023
Q3 		$221M Sell
3,239,648
-584,178
-15% -$49.6M 0.07% 280
2023
Q2 		$359M Sell
3,823,826
-464,499
-11% -$36.2M 0.11% 200
2023
Q1 		$291M Buy
4,288,325
+412,998
+11% +$26.5M 0.1% 224
2022
Q4 		$192M Buy
3,875,327
+197,740
+5% +$8.08M 0.07% 301
2022
Q3 		$119M Buy
3,677,587
+198,805
+6% +$8.2M 0.04% 405
2022
Q2 		$137M Buy
3,478,782
+707,851
+26% +$37.9M 0.05% 380
2022
Q1 		$194M Sell
2,770,931
-1,002,095
-27% -$73.3M 0.06% 344
2021
Q4 		$294M Buy
3,773,026
+404,721
+12% +$35.7M 0.08% 263
2021
Q3 		$322M Buy
3,368,305
+199,792
+6% +$21.1M 0.1% 211
2021
Q2 		$394M Sell
3,168,513
-54,362
-2% -$6.49M 0.12% 178
2021
Q1 		$425M Sell
3,222,875
-320,668
-9% -$43.9M 0.14% 157
2020
Q4 		$470M Sell
3,543,543
-211,917
-6% -$25.6M 0.17% 127
2020
Q3 		$383M Sell
3,755,460
-374,624
-9% -$32.4M 0.16% 141
2020
Q2 		$359M Buy
4,130,084
+752,408
+22% +$60.1M 0.15% 142
2020
Q1 		$196M Buy
3,377,676
+191,035
+6% +$15.5M 0.1% 207
2019
Q4 		$295M Buy
3,186,641
+194,117
+6% +$17.1M 0.12% 176
2019
Q3 		$271M Sell
2,992,524
-380,912
-11% -$43.4M 0.12% 183
2019
Q2 		$398M Sell
3,373,436
-915,597
-21% -$92.3M 0.18% 114
2019
Q1 		$371M Sell
4,289,033
-27,156
-0.6% -$2.31M 0.17% 123
2018
Q4 		$272M Buy
4,316,189
+1,770,503
+70% +$122M 0.14% 167
2018
Q3 		$201M Buy
2,545,686
+2,499,633
+5,428% +$163M 0.07% 287
2018
Q2 		$2.78M Sell
46,053
-27,967
-38% -$1.51M ﹤0.01% 2586
2018
Q1 		$2.98M Sell
74,020
-44,507
-38% -$2.17M ﹤0.01% 2511
2017
Q4 		$6.21M Sell
118,527
-71,724
-38% -$3.83M ﹤0.01% 1974
2017
Q3 		$8.96M Sell
190,251
-48,573
-20% -$1.96M ﹤0.01% 1664
2017
Q2 		$8.45M Sell
238,824
-1,206
-0.5% -$37.2K ﹤0.01% 1697
2017
Q1 		$5.68M Buy
240,030
+23,804
+11% +$472K ﹤0.01% 1939
2016
Q4 		$2.89M Buy
216,226
+49,372
+30% +$797K ﹤0.01% 2441
2016
Q3 		$3.1M Sell
166,854
-66,050
-28% -$1.16M ﹤0.01% 2334
2016
Q2 		$2.85M Buy
232,904
+206,016
+766% +$1.55M ﹤0.01% 2330
2016
Q1 		$181K Sell
26,888
-22,259
-45% -$142K ﹤0.01% 3550
2015
Q4 		$454K Sell
49,147
-74,488
-60% -$693K ﹤0.01% 3306
2015
Q3 		$2.22M Buy
123,635
+16,980
+16% +$390K ﹤0.01% 2558
2015
Q2 		$3.17M Buy
106,655
+22,726
+27% +$571K ﹤0.01% 2451
2015
Q1 		$1.85M Buy
83,929
+6,834
+9% +$173K ﹤0.01% 2627
2014
Q4 		$2.12M Buy
77,095
+47,181
+158% +$1.15M ﹤0.01% 2544
2014
Q3 		$581K Buy
29,914
+1,602
+6% +$29.4K ﹤0.01% 2998
2014
Q2 		$482K Sell
28,312
-9,725
-26% -$134K ﹤0.01% 3003
2014
Q1 		$539K Sell
38,037
-28,324
-43% -$383K ﹤0.01% 2936
2013
Q4 		$776K Sell
66,361
-3,351
-5% -$38.4K ﹤0.01% 2731
2013
Q3 		$824K Buy
69,712
+387
+0.6% +$4.97K ﹤0.01% 2738
2013
Q2 		$965K Buy
+69,325
New +$753K ﹤0.01% 2618

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Ameriprise's EXAS Position: Q1 2026 in Review

Ameriprise sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,717,958 shares — an estimated $174M sold.

Ameriprise first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $470M in Q4 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Ameriprise reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Ameriprise sold 1,717,958 Exact Sciences shares in Q1 2026, an estimated $174M.
  • Ameriprise first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Ameriprise's Exact Sciences position peaked at $470M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.